申请人:Temple University-Of The Commonwealth System of Higher Education
公开号:US20200392073A1
公开(公告)日:2020-12-17
Pharmaceutical compositions of the invention comprise functionalized N,N-dialkylamino phenyl ethers derivatives having a disease-modifying action in the treatment of diseases associated with lysosomal storage dysfunction that include Gaucher's disease, and any disease or condition involving lysosomal storage dysfunction.